Mather Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-35
Closed -$1.94K 963
2025
Q3
$1.94K Buy
+35
New +$1.75K ﹤0.01% 1539
2025
Q2
Sell
-35
Closed -$1.53K 963
2025
Q1
$1.53K Sell
35
-56
-62% -$2.84K ﹤0.01% 1599
2024
Q4
$5.14K Buy
91
+25
+38% +$1.56K ﹤0.01% 1376
2024
Q3
$4.5K Sell
66
-147
-69% -$8.3K ﹤0.01% 1318
2024
Q2
$14.7K Sell
213
-852
-80% -$46.9K ﹤0.01% 1337
2024
Q1
$78.8K Buy
+1,065
New +$67.4K ﹤0.01% 767

Other funds holding EXAS

Mather Group's EXAS Position: Q4 2025 in Review

Mather Group sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 35 shares — an estimated $1.94K sold.

Mather Group first reported a position in EXAS in Q1 2024 and held it in 6 quarters. The position peaked at $78.8K in Q1 2024. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Mather Group reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Mather Group sold 35 Exact Sciences shares in Q4 2025, an estimated $1.94K.
  • Mather Group first reported a position in Exact Sciences in Q1 2024 and held it in 6 quarters.
  • Mather Group's Exact Sciences position peaked at $78.8K in Q1 2024.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Mather Group's 13F filing for Q4 2025, filed 13 Jan 2026.